Mark Trudeau
CIK 1540412 · President and CEO · last filed 2025-11-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.50M
Companies
3
Total Filings
58
Lifetime Open-Market Net
-$7.00M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| TEL | Director | 7,123 | $210.38 | $1.50M | -$996.7K | 12 | 2025-11-14 |
| Keenova Therapeutics plc (MNK) Delisted | President and CEO | 11,312 | $0.34 | $3.8K | -$6.01M | 38 | 2022-06-21 |
| Covidien plc (COVw) Delisted | Senior Vice President | 29,262 | — | — | $0 | 8 | 2013-05-07 |
Recent Filings · Page 3 of 6
58 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2018-05-18 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +3,000 | $46.6K | EDGAR |
| 2018-04-04 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-01-05 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −7,014 | -$164.6K | EDGAR |
| 2018-01-04 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +3,535 | -$153.1K | EDGAR |
| 2017-11-14 | TEL | Mixed | +1,536 | -$47.8K | EDGAR |
| 2017-11-13 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +5,000 | $111.4K | EDGAR |
| 2017-06-12 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +1,000 | $40.2K | EDGAR |
| 2017-02-15 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +1,000 | $50.5K | EDGAR |
| 2017-01-06 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −3,339 | -$177.6K | EDGAR |
| 2017-01-04 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +73,655 | -$1.10M | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.